Recently Viewed

News Announcement

Onesource Specialty Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release

21-Apr-2026 Follow Value Research Online on Google download pdfDownload PDF Onesource Specialty Pharma

Press release: Orbiculars Partner secures tentative U.S. ANDA approval for a generic version of Ozempic (Semaglutide Injection) supported by OneSource as CDMO Partner.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.